Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
42.6M
-
Shares change
-
-2.59M
-
Total reported value, excl. options
-
$102M
-
Value change
-
-$6.94M
-
Put/Call ratio
-
2.11
-
Number of buys
-
39
-
Number of sells
-
-57
-
Price
-
$2.39
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q3 2020
117 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q3 2020.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.6M shares
of 237M outstanding shares and own 17.98% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (16.6M shares), BlackRock Inc. (5.47M shares), MARSHALL WACE, LLP (2.49M shares), 683 Capital Management, LLC (2M shares), Consonance Capital Management LP (1.56M shares), STATE STREET CORP (1.19M shares), SPHERA FUNDS MANAGEMENT LTD. (1.08M shares), FRANKLIN RESOURCES INC (1.03M shares), GEODE CAPITAL MANAGEMENT, LLC (979K shares), and Alyeska Investment Group, L.P. (970K shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.